http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
증례보고 : 에드워드 증후군 환아의 마취관리 -증례보고-
금창만 ( Chang Man Kum ),김미경 ( Mi Kyeong Kim ),길혜금 ( Hae Keum Kil ) 대한마취과학회 2006 Korean Journal of Anesthesiology Vol.51 No.1
Edward`s syndrome (trisomy 18) is the second most common chromosomal anomaly next to Down syndrome. The patients are dysmorphic, have multiple organ malformation which is made to die with 90% by 12 months. Information in the literature about anesthetic management in trisomy 18 is rare. We report the case of a 7 months old male with trisomy 18 who underwent inguinal hernioplaty and orchiopexy with general anesthesia. (Korean J Anesthesiol 2006; 51: 127~9)
임상연구 : 성상신경절 차단이 돌발성 난청의 치료에 미치는 영향
송종욱 ( Jong Wook Song ),심재광 ( Jae Kwang Shim ),문진천 ( Jin Cheon Moon ),안은경 ( Eun Kyoung Ahn ),금창만 ( Chang Man Kum ),윤덕미 ( Duck Mi Yoon ),이원상 ( Won Sang Lee ),신증수 ( Cheung Soo Shin ) 대한마취과학회 2006 Korean Journal of Anesthesiology Vol.51 No.1
Background: Idiopathic sudden sensorineural hearing loss (ISSNHL) is defined as a sensorineural hearing loss which develops abruptly without definitive causes. Stellate ganglion block (SGB) has been used as one of the treatment modalities in ISSNHL. However, published data establishing the effect of SGB has been slim. We conducted this study to evaluate the effect of SGB according to the factors that may influence the prognosis of the disease. Methods: We reviewed the records of 343 patients. The control group was managed with medications, and the SGB group was managed with SGB and the same medications. SGB was performed with 5 ml of 1.0% mepivacaine. The pure-tone audiogram was performed after the therapy and Siegel`s criteria was used to define the recovery of hearing. Results: The recovery rate of the SGB group was higher than that of the control group (58.1% vs. 42.1%, P < 0.05). The SGB group had a higher recovery rate than the control group in patients treated within 7 days from the onset of symptoms (66.9% vs. 44.1%, P < 0.05), without diabetes mellitus (58.5% vs. 44.9%, P < 0.05), without dizziness (61.6% vs. 44.6%, P < 0.05), or whose initial hearing loss was between 71 and 90 dB (69.4% vs. 38.9%, P < 0.05). Conclusions: SGB is thought to be a useful therapy for ISSNHL, especially in the patients treated within 7 days, without diabetes mellitus, dizziness, or whose initial hearing loss was severe. (Korean J Anesthesiol 2006; 51: 52~7)